Aug 12, 2023 · Taken together, these data suggest that targeting CREB signaling may be a promising approach for suppressing metastatic PCa in the molecular ...
People also ask
What are biomarkers in prostate cancer?
Biomarkers are molecules whose detection or evaluation provides information about a disease beyond standard clinical parameters. They can be detected in a variety of settings, including tissue samples, blood, and urine.
What is STAT3 in prostate cancer?
Activation of STAT3 signaling occurs in prostate cancer and it promotes malignant behavior of tumor cells. Induction of STAT3 signaling increases glycolysis and proliferation of prostate cancer cells and prevents apoptosis. Furthermore, STAT3 signaling induces EMT mechanism in increasing cancer metastasis.
What is PTEN deficiency in prostate cancer?
The tumor suppressor gene PTEN is one of the most often deleted genes in human prostate cancer. Loss of PTEN is an important event in prostate carcinogenesis. Metabolic reprogramming induced by PTEN loss fuels malignant growth and proliferation of prostate cancer cells.
Loss of Stat3 in a Pten-null mouse prostate model leads to a reduction of LKB1/pAMPK with simultaneous activation of mTOR/CREB, resulting in metastatic disease.
Missing: url? | Show results with:url?
In order to show you the most relevant results, we have omitted some entries very similar to the 2 already displayed.
If you like, you can repeat the search with the omitted results included. |